Skip to content

Neuropace, Inc. NPCE Indemnification liability accrued for officers and directors

Indemnification liability accrued for officers and directors at other companies

Precigen logo
PrecigenPGEN
-$184.25K+60.4%
Precigen logo
PrecigenPGEN
$0-100%
Achieve Life Sciences logo
Achieve Life SciencesACHV
$0
Resideo Technologies, Inc. logo
Resideo Technologies, Inc.REZI
$0-100%
Monro, Inc. logo
Monro, Inc.MNRO
$18.6M
Flagstar Bank
 logo
Flagstar Bank FLG
$583M-24.9%

Other financials

Income statement

See full
Revenue$22.1M-2.0%
Gross profit$18.0M+4.1%
Operating income-$5.6M-8.2%
Net income-$6.7M-1.5%
EPS (diluted)-$0.20+4.8%

Balance sheet

See full
Cash & equivalents$15.6M-42.4%
Total debt$70.5M-3.7%
Total equity$14.5M-40.4%
Total assets$98.9M-10.3%

Cash flow

See full
Operating cash flow-$5.9M+21.1%
CapEx$117.0K+216%
Free cash flow-$6.0M+20.0%

Valuation

See full
Market cap$557.77M+63.4%
Enterprise value$612.6M+58.1%
P/S5.6×+1.6×

Profitability

See full
Gross margin78.3%+3.5pp
Operating margin-16.8%-3.5pp
Net margin-21.7%-4.5pp
FCF margin-10.3%-3.5pp

Returns & leverage

See full
Return on equity-111.4%-13.1pp
Debt / equity4.9×+1.9×
Current ratio5.4×-1.2×

Where this comes from

Reported directly by Neuropace, Inc. in its filing.

Tagged under the XBRL concept npce:IndemnificationLiabilityOfficersAndDirectors.

The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuropace, Inc.'s indemnification liability accrued for officers and directors.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuropace, Inc.'s indemnification liability accrued for officers and directors?
Neuropace, Inc. (NPCE) reported indemnification liability accrued for officers and directors of $0 in Q1 2026.
What does indemnification liability accrued for officers and directors mean?
This represents the estimated liability for potential legal costs or damages that the company may be required to cover for its officers and directors under indemnification agreements. It serves as a measure of potential legal risk and the company's exposure to litigation. Investors monitor this to assess the company's governance risk and potential future cash outflows.